TRANSFUSION AND APHERESIS SCIENCE

Scope & Guideline

Innovating Patient Care Through Apheresis and Transfusion Insights

Introduction

Explore the comprehensive scope of TRANSFUSION AND APHERESIS SCIENCE through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore TRANSFUSION AND APHERESIS SCIENCE in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1473-0502
PublisherPERGAMON-ELSEVIER SCIENCE LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1996 to 2024
AbbreviationTRANSFUS APHER SCI / Transfus. Apher. Sci.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTHE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND

Aims and Scopes

The journal 'Transfusion and Apheresis Science' primarily aims to advance the field of transfusion medicine and apheresis through the dissemination of high-quality research and clinical practice insights. It encompasses a broad range of topics related to blood transfusion, blood component therapy, apheresis techniques, and the underlying immunological and genetic factors influencing these processes.
  1. Transfusion Medicine:
    Focuses on the efficacy, safety, and clinical outcomes associated with blood transfusions, including studies on transfusion reactions, management of blood components, and the impact of transfusion on various patient populations.
  2. Apheresis Techniques:
    Explores advancements in apheresis technology, including therapeutic plasma exchange and stem cell collection, with an emphasis on optimizing protocols and improving patient outcomes.
  3. Immunohematology:
    Investigates immunological aspects of blood transfusion, including alloimmunization, blood group antigens, and the genetic factors influencing transfusion compatibility and patient responses.
  4. Clinical Applications:
    Provides insights into clinical practices and guidelines for managing patients requiring transfusion or apheresis, addressing specific conditions such as hemophilia, sickle cell disease, and other hematological disorders.
  5. Emerging Therapies and Technologies:
    Highlights innovative approaches to transfusion and apheresis, including the use of convalescent plasma, gene therapies, and novel anticoagulant treatments.
The journal has recently highlighted several emerging themes and trends that reflect the evolving landscape of transfusion medicine and apheresis. These themes indicate a proactive approach to addressing contemporary challenges and innovations in the field.
  1. COVID-19 Related Research:
    Numerous publications focus on the role of convalescent plasma and other blood products in treating COVID-19, indicating a significant trend towards understanding the implications of pandemics on transfusion practices.
  2. Personalized Medicine in Transfusion:
    An increasing interest in personalized approaches to transfusion and apheresis, including the use of genetic information to guide therapy and optimize outcomes for individual patients.
  3. Artificial Intelligence and Automation:
    Emerging research is focusing on the application of artificial intelligence and automation in transfusion medicine, aiming to enhance efficiency, safety, and decision-making in clinical practice.
  4. Ethical and Policy Considerations:
    A growing body of work addresses the ethical implications and policy considerations surrounding blood donation, transfusion practices, and patient consent, reflecting an increased awareness of social responsibility in healthcare.
  5. Innovations in Apheresis Techniques:
    An uptick in studies related to novel apheresis techniques and their applications in various medical conditions, suggesting a trend towards more specialized and effective treatment modalities.

Declining or Waning

As the field of transfusion medicine evolves, certain themes and topics have seen a decline in focus within recent publications. This reflects shifts in research priorities and emerging challenges in the field.
  1. Traditional Transfusion Practices:
    There is a noticeable decrease in studies centered around conventional blood transfusion practices as research increasingly emphasizes evidence-based practices and innovative solutions to transfusion-related challenges.
  2. Infectious Disease Transmission:
    Research on infectious disease transmission through blood transfusion has diminished as advancements in screening and pathogen reduction technologies have led to improved safety measures.
  3. Surgical Transfusion Protocols:
    Fewer articles are appearing on transfusion protocols specific to surgical settings, possibly due to evolving practices that focus more on patient blood management strategies rather than traditional protocols.
  4. Non-therapeutic Apheresis Applications:
    Research exploring non-therapeutic applications of apheresis has declined, as the focus shifts towards more clinically relevant uses, such as therapeutic plasma exchange and stem cell collection.

Similar Journals

AMERICAN JOURNAL OF HEMATOLOGY

Empowering Discoveries in Blood Disorders
Publisher: WILEYISSN: 0361-8609Frequency: 12 issues/year

American Journal of Hematology, published by Wiley, stands as a premier outlet for the dissemination of cutting-edge research in the field of hematology. With a commendable impact factor and ranked #9 out of 137 in the Scopus medicine category, this journal has established a robust presence since its inception in 1976. Operating in the Q1 quartile for hematology, it serves as a crucial resource for researchers, clinicians, and students dedicated to understanding blood disorders and advancing treatment methodologies. While the journal does not currently offer open access options, it remains highly regarded for its rigorous peer-review process and impactful contributions to the scientific community. With coverage extending into 2024, the American Journal of Hematology is committed to fostering innovation and collaboration within the hematological sciences.

Indian Journal of Hematology and Blood Transfusion

Empowering Healthcare Through Cutting-edge Hematology Research
Publisher: SPRINGER INDIAISSN: 0971-4502Frequency: 4 issues/year

Indian Journal of Hematology and Blood Transfusion, published by SPRINGER INDIA, serves as a leading platform for disseminating original research, reviews, and case studies in the field of hematology. With an ISSN of 0971-4502 and E-ISSN 0974-0449, this journal has been instrumental in advancing knowledge from 2000 to 2024, providing insights into critical issues surrounding blood disorders and transfusion practices. Currently ranked in the Q3 category for Hematology for 2023, it reflects a commitment to high-quality scientific content amidst a competitive landscape where it ranks 97/137 in Scopus for Medicine - Hematology, placing it in the 29th percentile of its peers. The journal primarily addresses a diverse readership, including researchers, healthcare professionals, and students, aiming to foster innovation and collaboration within the field. Although it operates under a subscription model, access options for individual articles and institutional subscriptions ensure that valuable research is disseminated widely to enhance medical practice and education in hematology.

Journal of Hematology

Empowering Research, Transforming Lives
Publisher: ELMER PRESS INCISSN: 1927-1212Frequency: 4 issues/year

The Journal of Hematology, published by ELMER PRESS INC, serves as a pivotal platform for disseminating cutting-edge research in the field of hematology. With an ISSN of 1927-1212 and an E-ISSN of 1927-1220, this journal is committed to advancing scientific knowledge and clinical practice through high-quality peer-reviewed articles encompassing all aspects of blood disorders, from basic science to health policy implications. While the journal currently operates under a traditional access model, it nonetheless prioritizes the rapid publication of significant findings, ensuring that researchers, clinicians, and students have timely access to the latest advancements in hematological research. Positioned to bridge gaps in knowledge and foster collaboration among scholars worldwide, the Journal of Hematology is an essential resource for anyone invested in this vital area of medicine.

Transfusionsmedizin

Elevating transfusion practices through peer-reviewed excellence.
Publisher: GEORG THIEME VERLAG KGISSN: 2191-8805Frequency: 4 issues/year

Transfusionsmedizin is a premier journal dedicated to the field of transfusion medicine, published by the renowned GEORG THIEME VERLAG KG. With an ISSN of 2191-8805 and an E-ISSN of 2191-8813, this journal serves as a vital platform for disseminating cutting-edge research and clinical advancements in blood transfusion practices. Although it operates under a subscription model, the journal is committed to high-quality peer-reviewed content that addresses contemporary challenges and innovations in transfusion therapy. By fostering dialogue among researchers, clinicians, and students, Transfusionsmedizin aims to advance patient care and enhance the safety and efficacy of transfusion practices globally. Its contributions are essential for professionals engaged in transfusion science, hematology, and related medical fields, solidifying its reputation as a critical resource for staying abreast of the latest developments in transfusion research.

Egyptian Journal of Haematology

Navigating the Future of Hematology with Rigorous Research
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1110-1067Frequency: 4 issues/year

The Egyptian Journal of Haematology, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, stands as a pivotal resource in the field of hematology, particularly within the context of Egypt and the broader Middle Eastern region. This journal is dedicated to disseminating high-quality research that explores the latest advancements in blood disorders, hematologic malignancies, and transfusion medicine. With a focus on original research, case studies, and reviews, it aims to provide a comprehensive platform for hematologists, researchers, and healthcare professionals to enhance their understanding and management of hematological conditions. Although it is not an open-access journal, the rigorous peer-review process ensures that only the most impactful studies are published, contributing to the journal's reputation in the academic community. The Egyptian Journal of Haematology serves as an essential tool for advancing knowledge, improving clinical outcomes, and fostering collaboration among experts in the field.

BRITISH JOURNAL OF HAEMATOLOGY

Exploring Innovations in Blood Health and Disease
Publisher: WILEYISSN: 0007-1048Frequency: 23 issues/year

British Journal of Haematology, published by Wiley, is a leading journal in the field of hematology, with an impressive impact factor reflecting its significance in the medical research community. Established in 1955, the journal has consistently contributed to advancing knowledge in hematology, currently holding a prestigious Q1 ranking in the Scopus category of Hematology, placing it in the top 18% of the field. The journal encompasses a broad range of topics including clinical and laboratory aspects of blood disorders and hematological malignancies, making it an essential resource for hematologists, researchers, and healthcare professionals. With its commitment to publishing top-tier research and clinical studies, the British Journal of Haematology plays a critical role in shaping treatment approaches and improving patient outcomes worldwide. Please note that this journal does not offer Open Access options, ensuring that published content is rigorously curated for quality and relevance.

Clinical Laboratory

Fostering Collaboration in Clinical Laboratory Practices
Publisher: CLIN LAB PUBLISSN: 1433-6510Frequency: 12 issues/year

Clinical Laboratory is a reputable journal dedicated to the interdisciplinary field of clinical biochemistry, genetics, and molecular biology. Published by CLIN LAB PUBL in Germany, this journal provides a platform for the dissemination of original research, reviews, and key insights into laboratory practices and innovations that play a crucial role in modern medicine and diagnostics. With an ISSN of 1433-6510 and a consistent publication history since its inception in 1964 and converging through 2024, it is indexed within the Scopus database, ranking in the 30th percentile among its peers. Although classified in the third quartile for 2023 in the field, Clinical Laboratory continues to contribute valuable knowledge and fosters collaboration among researchers, professionals, and students. Notably, it does not currently operate as an Open Access journal, which emphasizes its commitment to maintaining high-quality peer-reviewed content accessible through institutional and library subscriptions. For those in the domain, Clinical Laboratory serves as a vital resource for the latest advancements and trends shaping the future of clinical laboratory science.

Asian Journal of Transfusion Science

Connecting global minds in transfusion medicine.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0973-6247Frequency: 2 issues/year

Asian Journal of Transfusion Science, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, is a prominent open-access journal dedicated to the interdisciplinary fields of hematology and immunology. With an ISSN of 0973-6247 and E-ISSN 1998-3565, it serves as a crucial platform for researchers, clinicians, and students from around the globe, facilitating the dissemination of high-quality, peer-reviewed research. Established in 2007, the journal has consistently aimed to advance scientific knowledge in transfusion practices, enhancing patient care and safety in transfusion medicine. Despite its recent categorization in the Q4 quartile within both Hematology and Immunology, the journal is making strides toward greater visibility in the academic community, with plans for expanded reach and increased citation impact. With its commitment to open-access publishing, the Asian Journal of Transfusion Science ensures that invaluable research findings are readily accessible to all stakeholders, thereby bolstering collaborative efforts in transfusion science and related disciplines.

BLOOD

Elevating Excellence in Hematological Studies.
Publisher: AMER SOC HEMATOLOGYISSN: 0006-4971Frequency: 52 issues/year

BLOOD, published by the American Society of Hematology, is a premier peer-reviewed journal in the fields of Biochemistry, Cell Biology, Hematology, and Immunology. With an impressive impact factor and ranking in the top quartiles (Q1) across multiple disciplines, BLOOD is essential reading for researchers and professionals seeking to stay updated on the latest advancements in hematology and related fields. The journal has been a cornerstone of hematological research since its inception in 1946, providing a platform for rigorous scientific inquiry and discourse. Its commitment to publishing high-quality original research, comprehensive reviews, and insightful editorials makes it a vital resource for students, practitioners, and scientists alike. By offering exceptional access to influential publications, BLOOD continues to shape the future of hematology and enhance understanding of blood-related disorders, marking its vital role in advancing both basic and clinical research.

Anemia

Empowering researchers with open access to vital hematological insights.
Publisher: HINDAWI LTDISSN: 2090-1267Frequency: 1 issue/year

Anemia is a distinguished open-access journal published by HINDAWI LTD, focusing on the intricate and vital field of hematology and related disciplines. Since its inception in 2010, this journal has been dedicated to advancing our understanding of blood disorders, with a particular emphasis on anemia, through the dissemination of high-quality research that is freely accessible to a global audience. The journal's evolving scope from its founding through 2024 embodies its commitment to include the latest breakthroughs and methodologies in cell biology and hematological research. With its presence in prestigious databases and a tiered ranking that places it in the Q3 category in Hematology and Q4 in Cell Biology as of 2023, Anemia serves as an invaluable resource for researchers, clinicians, and students alike. The journal is indexed with a respectable position in Scopus, ranking 52 out of 137 in Hematology, highlighting its growing influence in the medical and scientific communities. With continued emphasis on open access, Anemia not only fosters collaborative research but also ensures that crucial findings reach those who need them most, enhancing educational outcomes and clinical practices worldwide.